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Abstract 
 
Background: Obesity is a prevalent and worldwide health problem . The most common weight loss method preferred 
by obese individuals is dietary supplements. This study was performed in order to determine the dietary supplements 
used by obese individuals for weight loss and to examine the barriers to informing health personnel on supplement use. 
Materials and Methods: This descriptive study was performed in the Endocrinology and Diabetes Polyclinic at the 
Endocrinology and Metabolic Diseases Department of the Health Application and Research Center of the Bulent Ecevit 
University. The sample consisted of 151 patients randomly selected from among the 755 people using the simple 
randomization method. 
 Results: In the study, 33.6% of the obese individuals were found to use dietary supplements for weight loss. Women, 
people with no chronic diseases, people who exercised regularly, and people who underwent regular health check-ups 
were found to prefer dietary supplements at a greater rate (p<0.05). It was found that 82.5% of the obese individuals 
used dietary supplements without informing health personnel. 
Conclusion: One thirds of obese individuals were using dietary supplements for weight loss, while the majority of 
supplement users did not inform health personnel. To increase patient safety, the patients using dietary supplements 
should be closely monitored, and the use of dietary supplements should be evaluated on a routine basis. 
 
Key Words: Obesity, dietary supplement, weight loss, Turkey 
 
 
Introduction 
 
  Obesity is defined by the World Health Organization (WHO) as abnormal or excessive fat accumulation in the 
body which harms health. Obesity is a prevalent and worldwide health problem and is the fifth most important reason 
for global deaths (http://www.who.int/mediacentre/factsheets/fs311/en/(Access date:26.08.2016). Each year at least 2.8 
million adults die because of being obese or overweight (Chandresekaran et al., 2012). According to the Turkey 
Diabetes Prevalence Studies TURDEP I (1998) and TURDEP II (2010), the prevalence of obesity has increased from 
22.3% to 31.2% in Turkey. On the other hand, 37.5% of the Turkish population is overweight (Satman I and TURDEP-
II Study Group (http://www.turkendokrin.org/files/file/TURDEP_II_2011.pdf)(Access date: 26.08.2016)  Clinical 
guidelines state that successful weight loss and maintenance  can only be achieved through lifestyle changes such as 
reducing calorie intake and increasing physical activity level (Pillitteri et al., 2008). However, due to lack of time and 
sedentary lifestyles, these two methods cannot be regularly practiced (Chandresekaran et al., 2012). Considering that 
such lifestyle changes are relatively difficult to implement, the demand for dietary supplements are introduced in 
commercials with big claims and these products can easily be obtained without prescriptions. A limited number of 
studies have investigated the effectiveness and reliability of dietary supplements but the numbers of studies in this area 
have increased (Saper et al., 2004; Pillitteri et al., 2008; Berg and Walsh, 2013).  
 Thus, it can be said that obese patients enter the search for alternative health approaches for weight loss 
(Bertish et al., 2008). It has been reported that obese individuals prefer complementary and alternative medicine 
methods (CAM) such as herbal products, dietary supplements, yoga, acupuncture, acupressure, homeopathy, and 
hypnotherapy, with dietary supplements being the most common method (Steyer and Ables, 2009). The Dietary 
Supplement Health and Training Law (DSHEA) (1998) has defined a dietary supplement as a product supplementing 
foodstuff.  
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In the USA, after a death in 1962, it has become law that the effectiveness of a dietary supplement should be proven 
before being marketed. The American Food and Drug Administration manages all aspects of the production, product 
characteristics, reliability, and post marketing monitoring of dietary supplements (Dwyer et al., 2005; Decker and Lee, 
2010; Erdogan and Cınar, 2014).   
 In the USA, among healthy adults, the prevalence of the use of dietary supplements varies between 15.2% 
(Blanck et al., 2007) and 33.9% (Pillitteri et al., 2008). However, when the literature is examined, only two studies on 
the CAM usage of obese individuals for weight loss could be found, and no studies on dietary supplement use could be 
found at all. In these studies, individuals mostly used CAM methods and dietary supplements without the knowledge of 
health personnel (Blanck et al., 2007; Bertish et al., 2008). It can be said that the evidence supporting these methods for 
weight loss are not at  satisfying levels (Pittler and Ernst, 2005). For this reason, if a patient wants to use dietary 
supplements for weight loss, it should be recommended that he/she uses methods that have evidence for quality, safety, 
and effectiveness and patients should be monitored for the side effects of these methods as well as their beneficial 
effects. This study was planned and carried out due to the e lack of studies on the topic.  The current study aimed to 
determine the dietary supplements used by obese individuals for weight loss and to examine the barriers to informing 
health personnel on supplement use. 
 
Materials and Methods 
Design, Setting, and Sample 
 
 This descriptive study was performed in the Endocrinology and Diabetes Polyclinic at the Endocrinology and 
Metabolic Diseases Department of the Health Application and Research Center of the Bulent Ecevit University. The 
universe of the study consisted of 755 obese patients presenting at the Endocrinology and Diabetes Polyclinic between 
January 2016 and June 2016. The sample of the study consisted of 151 patients randomly selected from among the 755 
people using the simple randomization method. Patients who were 18 years of age and above, were diagnosed with 
obesity, had no mental or communication problems, and volunteered to participate in the study were included in the 
sample. The height and weight measurements were performed by a polyclinic nurse, and BMI’s were calculated. The 
exercise levels of the individuals were questioned in line with the suggestions of the Center of Disease Control and 
Prevention (CDC) as 2.5 hours of middle intensity aerobic activity per week (brisk walking) and 2 hours or more of 
muscle strengthening exercises working out all major muscle groups a week (legs, hips, back, abdomen, torso, 
shoulders, and arms) (http://www.cdc.gov/physicalactivity/basics/adults/index.htm) Access date: December, 2015)   
 
Data collection 
 
Data was collected using a questionnaire which was administered face-to-face and which included questions 
on socio-demographic characteristics, dietary supplement usage, dietary supplement types used by patients, and other 
questions about dietary supplement usage. A total of 21 questions were asked. Data collection took approximately 15 
minutes. The height and weight measurements, as well as the BMI calculations of the patients presenting at the 
polyclinic were performed by a diabetes nurse. 
 
Ethical Considerations 
 
Prior to the study, written permission was taken from the Bulent Ecevit University Clinical Research Ethical 
Board. Each patient was informed about the study and written informed consent was taken from the patients. 
 
Statistical analysis 
 
By using the SPSS 11.5 package software for data analysis, the percentage, average and chi-square tests were 
conducted. The level of statistical significance was accepted as p<0.05. 
 
Results 
 
The mean age of the individuals was 41.48  7.41, while 64.2% were female, and most of them were 
elementary school graduates (23.8%), housewives (39.7%), and married (73.5%) people with medium income levels 
(66.9%). It was found that 42.4% of the obese individuals had chronic diseases, with diabetes being the most 
widespread. The mean BMI of the obese individuals was 40.82±3.33. Almost half (56.3%) of the individuals received 
drug treatments and had routine check-ups (53.7%), whereas 34.4% performed regular exercise. In this context, the 
exercise levels of the individuals were questioned in line with the suggestions of the Center of Disease Control and 
Prevention (CDC) as 2.5 hours of middle intensity aerobic activity per week (brisk walking) and 2 hours or more of 
muscle strengthening exercises working out all major muscle groups a week (legs, hips, back, abdomen, torso, 
shoulders, and arms). 
The characteristics of the obese individuals regarding dietary supplement use were given in Table 1. In our 
study, 33.6% of obese individuals were found to use dietary supplements for weight loss. The most commonly used 
supplements were found to be commercial names gano excel (41%) and herbalife (37.2%), form teas (33.3%), and 
 61 
 
commercially named FX15 (29.4%) containing zinc, vitamin C, grape seed extract, and green tea extract and, weight 
loss pills (11.7%) containing acai extract, green tea, vitamin C, and soya oil. It was determined that 53% of the 
individuals reported to benefit from these products, while 62% stated that they came to no harm. Also, 62.82% of the 
individuals stated that they used these products on a daily basis (87.8%) for 4 months and more. As it can be seen in 
Table 1, 82.3% of the obese individuals used these products without the knowledge of health personnel. The reasons 
for not telling health personnel about supplement use included health personnel not asking about the use of dietary 
supplements (68.6%), not feeling the need to tell (37.2%), health personnel not approving (23.52%), and thinking that 
health personnel would not have any information on the subject (17.6%). The sources where the obese individuals 
learned about the products were family-friends (54.9%), media/TV (21.6%), drugstores (21.6%), and the Internet 
(17.64%). The purchases of the products were made from drugstores (39%), pharmacies (31%), and the Internet (29%). 
It was found that 88.3% of the obese individuals stated that they partially or wholly benefited from the products (Table 
1) 
 
Table 1: The characteristics of the obese individuals regarding dietary supplement use 
 
Variable name N=51        % 
Use of dietary supplements 
Yes 
No 
51 
100 
33,6 
65,8 
Commercially name of the 
dietary supplement* 
Gano excel  
Herbalife  
Form tea 
FX15  
Weight loss pill 
Green tea 
Rosemary tea 
Kombu tea 
21 
19 
17 
15 
6 
5 
3 
1 
41,0 
37,2 
33,3 
29,4 
11,7 
9,8 
5,8 
2 
 
 
Benefiting 
Yes 
No 
Partially 
27 
  7 
17 
53,0 
13,7 
33,3 
 
Harm 
 
Yes 
No 
Partially 
3 
32 
16 
6,0 
62,7 
31,3 
Health personnel 
knowledge 
Yes 
No 
9 
42 
17,65 
82,35 
Reason if no* Doesn’t ask 
Don’t need to 
Wouldn’t approve 
No information 
35 
19 
12 
9 
68,62 
37,25 
23,52 
17,64 
Who recommended the 
product* 
Family/friends 
Media/TV 
Drugstore 
Internet 
Health personnel 
Pharmacy 
 
28 
11 
11 
9 
2 
2 
 
54,9 
21,5 
21,5 
17,64 
3,9 
3,9 
Purchase İnternet 
Drugstore 
Pharmacy 
15 
20 
16 
29,4 
39,2 
31,4 
 
Use duration 
3 months or less 
4 months or more 
19 
32 
37.2 
62.8 
 
Use frequency 
Everyday  
1-3 days a week 
43 
8 
87.8 
12.2 
 *More than one option was selected. 
 
The factors related to the dietary supplement use of obese individuals based on sociodemographic 
characteristics were given in Table 2. It was found that women preferred dietary supplements more often (p<0.03), 
while supplement use did not show significant differences according to age, educational level, income level, social 
security, occupation, and marital status(p>0.05). 
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Table 2: The factors related to the dietary supplement use of obese individuals based on sociodemographic 
characteristics 
 
Variables Dietary Supplement 
 Did not use (n=100) 
 Dietary Supplement 
 Used (n=51) 
 p 
 Age (years)  
18-39 
40 and above 
  
32 (60.4) 
68 (69.4) 
 
  
 21 (39.6) 
 30 (60.4) 
 
0.35 
  Gender 
  Female 
  Male 
 
59 (60.8) 
41 (75.9) 
 
38 (39.2) 
13 (24.1) 
 
0.03 
 Marital status 
  Single 
  Married 
 
26 (35.6) 
74 (66.7) 
 
 14(35.0) 
 37(33.3) 
 
0.49 
 Education 
  Literate 
  Elementary 
  High school 
  College 
 
  6 (2.0) 
42 (7.2) 
30 (68.8) 
22 (66.2) 
 
  2 (1.3) 
19 (27.8) 
20 (31.3) 
10 (33.8) 
 
 
0.67 
 Social security 
  Yes 
  No 
 
 98(67.1) 
   2(40.0) 
 
 48 (32.9) 
   3 (60.0) 
 
 
0.33 
 Level of income 
  Poor 
  Moderate 
  Good 
 
10 (9.8) 
72 (63.8) 
18 (17.5) 
 
  4 (7.8) 
29 (56.9) 
18 (35.3) 
 
 
0.06 
 
 
The use of dietary supplements by obese individuals according to other characteristics was given in Table 3. In 
our study, individuals with no chronic diseases were found to use dietary supplements more often (p=0.00). When other 
characteristics were examined, it was found that BMI did not affect dietary supplement use, with those who regularly 
exercise and those who go for routine check-ups preferring the use of such products more often (p=0.01). 
 
Table 3: The use of dietary supplements by obese individuals according to other characteristics 
 
Variables Dietary Supplement 
 Did not use (n=100) 
Dietary Supplement 
 used (n=51) 
P 
Presence of a chronic disease 
  Yes 
  No  
 
 
49 (48.6) 
51 (50.4) 
 
 
15 (29.4) 
36 (70.6) 
 
 
0.01 
 Attending regularcheck-ups 
 Yes 
 No 
 
47(59.5) 
53(76.8) 
 
35(40.5) 
16 (23.2) 
 
0.01 
 Regular exercise 
  Yes           
  No 
 
27 (53.8) 
73 (72.7) 
 
24 (46.2) 
27 (27.3) 
 
0.02 
BMI 40.82±3.33 
 
39.96±7.11 0.48 
 
Discussion 
 
In the current study, 33.6% of obese individuals were found to use dietary supplements for weight loss. 
Similarly, in the USA, among healthy adults, the prevalence of the use of dietary supplements varies between 15.2% 
(Blanck et al., 2007) and 33.9% (Pillitteri et al., 2008). This finding shows that the level of dietary supplement use in 
our sample is similar to developed countries, suggesting that the approaches to the problem could be similar as well. 
In this study, it was seen that women more commonly preferred dietary supplements, while age, educational 
level, income level, social security, occupation, and marital status were not related to dietary supplement use. Similarly, 
Blanck, Amariles, and Pillitteri have also reported that overweight and obese women more commonly used 
complementary therapies and products (Amariles et al., 2006; Blanck et al., 2007; Pillitteri et al., 2008). In studies 
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regarding the use of complementary methods and dietary supplements among healthy adults, dietary supplement use 
was reported to be higher in those with lower education levels (Pillitteri et al., 2008), lower income levels (Blanck et 
al., 2007; Pillitteri et al., 2008) those with no social security (Pillitteri et al., 2008) and those between 18 and 34 years 
of age (Blanck et al., 2007). Consistent with our findings, Blanck et al. (2017) found that dietary supplement use for 
weight loss was not associated with educational level in healthy adults. In studies evaluating the use of CAM methods 
in various populations, CAM use was found not to be affected by sociodemographic characteristics including age, 
gender, marital status, education, and income level (Erdogan et al., 2012; Erdogan et al., 2013) In the present study, it 
was found that sociodemographic characteristics other than gender were not associated with dietary supplement use, 
which is in line with previous studies conducted with various populations (Erdogan et al., 2012; Erdogan et al., 2013). 
In the current study, individuals with no chronic disease were found to use dietary supplements at higher rates, and 
when other characteristics were examined, it was determined that BMI did not affect dietary supplement use, while 
poeple who regularly exercised and who attended routine check-ups more often preferred to use dietary supplements. 
In previous studies conducted with different groups, individuals with chronic diseases were reported to use CAM 
methods at higher rates (Loera et al., 2007; Erdogan et al., 2013; Falci et al., 2016; Erdogan et al., 2017). In the present 
study study, individuals with no chronic disease were found to more commonly use dietary supplements. In a study 
where Sharpe et al. examined the use of CAM methods for weight loss in adults, it was reported that adults with heart 
disease, diabetes, or hypertension did not use any CAM methods (Sharpe et al., 2007).  This result is inconsistent with 
our results as well as with other findings in the literature. The reason behind this inconsistency may be related to the 
fact that our sample was different from Sharpe et al.’s group. Additionally, there have been many news in the media 
regarding the life threatening results of the use of such dietary supplements by obese individuals. Individuals with 
chronic diseases may not be using these supplements since they are afraid of the interactions the supplements may have 
with their drug treatment. Moreover, since most of the obese individuals use these products without the knowledge of 
health personnel, those with chronic diseases may avoid using such methods due to health complications. 
Clinical guidelines state that successful weight loss and maintenance is only possible through lifestyle changes 
such as reducing calorie intake and increasing physical activity (Pillitteri et al., 2008). When we questioned the exercise 
levels of obese individuals, we found that those who exercised more commonly used dietary supplements. Participants 
who engaged in regular exercise also used these products. This finding suggests that these participants are determined 
to lose weight and want to use non pharmacological methods as well. Similarly, in Sharpe et al’s study, participants 
who exercised for weight control were found to use CAM methods at higher rates (Sharpe et al., 2007). In a study 
conducted with obese individuals, Amariles et al. reported that exercise level did not affect CAM usage (Amariles et 
al., 2006). This study does not support the findings of our study, which may be explained by the differences in both 
sample size and the questioning method. 
In the current study, BMI was found not to affect dietary supplement use. In studies where dietary supplement 
and CAM method use for weight control in normal adults were evaluated, people who were mildly obese (Bertish et al., 
2008) and overweight (Sharpe et al., 2007) were found to use more CAM methods for weight loss (Bertish et al., 2008) 
whereas obese individuals were found to prefer dietary supplements more often (Pillitteri et al., 2008).  It can be 
concluded that dietary supplement use increased as BMI increased. The results of previous studies are not in line with 
our findings. The reason behind this inconsistency may be explained by the fact that our entire sample consisted of 
obese individuals. 
In the present study, individuals who attended regular check-ups were found to use dietary supplements at 
higher rates. Individuals without chronic diseases also preferred this supplement. The majority of our sample was also 
found to use supplements without the knowledge of health personnel. Thus, the fact that these products were preferred 
by people who attended regular check-ups and who had no chronic diseases may be explained by the fear experienced 
by patients due to the possible side effects of dietary supplements. 
In the literature, both in studies performed in different disease groups (Kara, 2009; Erdogan et al. 2012; 
Erdogan et al., 2013) and in this study, people who used dietary supplements and CAM methods were found to largely 
do so (82.3%) without the knowledge of health personnel, taking the supplements in conjunction with drug treatment 
and not informing their doctors because their use of herbal supplements was never questioned by health personnel 
(Kara, 2009).  
When the reasons for not telling health personnel about dietary supplement use were questioned, the reasons 
were listed as health personnel not asking about the use of dietary supplements, not feeling the need to tell , health 
personnel not approving ,and thinking that health personnel would not have any information on the topic. In Blanck et 
al’s study, only one thirds of the individuals reported dietary supplement use to health personnel, and in Bertisch et al’s 
study 38-42% of the individuals reported dietary supplement use to health personnel (Blanck et al., 2007; Bertisch et 
al., 2008).  These results were in parallel to our study. The provision of the products was made from drugstores (39%), 
pharmacies (31%), and the Internet (29%), and individuals mostly learned about these products from friends and 
family. In previous studies performed with different patient groups, patients were reported to learn about CAM 
methods from other patients, family and friends, the Internet, TV, health personnel, and drugstores (Erdogan et al., 
2012; Erdogan et al., 2013). Dietary supplements, which are sold both with prescriptions and over the counter (OTC), 
have to be approved by the FDA before being presented to consumers (Erdogan and Cınar, 2014).  This process of 
approval requires clinical studies to determine the reliability, effectiveness, possible interactions, and appropriate 
dosage of a drug. However, dietary supplements can be marketed without FDA approval and without scientific 
approval of their reliability or effectiveness. Today, various dietary supplements were shown to have drug interactions, 
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with ties to serious health risks (Pillitteri et al., 2008). Thus, usage without the knowledge of health personnel may 
cause unwanted situations. Since most of the patients using such methods would have strong beliefs regarding these 
methods, they may avoid talking with health personnel on the subject. Thus, health personnel should question CAM 
methods used and dietary supplement usage when taking anamnesis, be open in communication, and not be judgmental 
(Erdogan et al., 2014).   
 
Conclusion 
 
In this study it was found that one thirds of obese individuals were using dietary supplements for weight loss, 
and the majority of the sample used such supplements without the knowledge of health personnel. When it is 
considered that the majority of obese individuals do not report their use of such products to health personnel, it can be 
suggested that the dietary supplement use of obese individuals should be routinely evaluated in order to increase patient 
safety, monitor the patients using CAM methods, and provide holistic care. Women, those with no chronic diseases, 
those who exercised regularly, and those who underwent regular health check ups were found to prefer dietary 
supplements at a greater rate. When taking anamnesis, these characteristics of patients should be taken into 
consideration and their use of dietary supplements should be questioned, a field in the patient file should be formed for 
the use of these products, and the applications used should be recorded. Health personnel should evaluate the personal 
beliefs of patients regarding the use of such products, and monitor how care is affected when patients seek out such 
methods. If these methods are going to be recommended as part of a weight loss program, randomized controlled 
studies with well-planned methodologies should be performed in the future. Thus, health personnel should follow 
scientific studies with high evidence levels regarding the safety, effectiveness, and interactions of dietary supplements, 
and use their results to correctly direct healthy individuals/patients (Erdogan and Cınar, 2014; Erdogan et al., 2014).    
 
Conflict of interest: The authors declare that they have no conflicting interests. 
 
Acknowledgements: We would like to thank Diabetes Nurse Safiye Catalcam and Prof. Dr. Taner Bayraktaroğlu for 
his assistance with the study. 
 
References 
 
1. Amariles, P., Gonzalez, L. and Giraldo, NA. (2006). Prevalence of self-treatment with complementary products and 
therapies for weight loss: A randomized, cross-sectional study in overweight and obese patients in Colombia. Current 
Therapeutic Research, 67: 66-78. 
2. Berg, L. and Walsh, C. (2013). Herbal weight-loss products: how informed are we? South African Journal of Clinical 
Nutrition, 26:41-43. 
3. Bertisch, SM., Wee, CC. and McCarthy, EP. (2008). Use of complementary and alternative therapies by overweight 
and obese adults. Obesity (Silver Spring), 16:1610–15.  
4. Blanck, HM., Serdula, MK., Gillespie, C., Galuska, DA., Sharpe, PA., Conway, JM., Khan, LK. and Ainsworth, BE. 
(2007). Use of Nonprescription dietary supplements for weight loss is common among Americans. Journal of the 
American Dietetic Association, 107: 441-447. 
5. CDC. http://www.cdc.gov/physicalactivity/basics/adults/index.htm) Access date: December, 2015) 
6. Chandresekaran, CV., Vijayalakshmi, MA., Prakash, K., Bansal, VS., Meenakshi, J. and Amit, A. (2012). Review 
article: herbal approach for obesity management. American Journal of Plant Sciences, 3: 1003-14. 
7. Decker, G. and Lee, CO. (2010). Complementary and alternative medicine (CAM) therapies in integrative Oncology. 
Handbook of Integrative Oncology Nursing: Evidence-Based Practice, 626-654. 
8. Dwyer, OT., Allison, DB. and Coates, PM. (2005). Dietary supplements in weight reduction. Journal of the American 
Dietetic Association, 105: S80-S86. 
9. Erdogan, Z. and Çınar, S. (2014). Oncology nursing, In: Complementary and alternative approaches used in oncology, 
Ed: Assoc. Dr. Gülbeyaz Can, Nobel Medical Bookstore. 275-288. 
10. Erdogan, Z.,  Atik, DO. and Cinar, S. (2014). Complementary and alternative medicine methods in chronic renal 
failure. Archives Medical Review Journal, 23: 770-86. 
11. Erdogan, Z., Cil, Akıncı, A., Emre, Yavuz, D., Kurtulus, Tosun, Z. and Atik, D. (2017). Use of complementary and 
alternative medicine methods among elderly people living in nursing homes. Kafkas Journal of Medical Sciences, 
7:60–66. 
12. Erdogan, Z., Çınar, S. and Şimşek, S. (2013). The relationship between hopelessness level and the use of 
complementary medicine methods in hemodialysis patients. Spatula DD - Peer Reviewed Journal on Complementary 
Medicine and Drug Discovery, 3:107–12. 
13. Erdogan, Z., Oguz, S. and Erol, E. (2012). Use of complementary therapies in the patients with heart disease. Spatula 
DD - Peer Reviewed Journal on Complementary Medicine and Drug Discovery, 2: 135-39.  
14. Falci, L., Zaixing, S. and Greenlee, H. (2016). Multiple chronic conditions and use of complementary and alternative 
medicine among US adults: Results from the 2012 National health interview survey. Preventing Chronic Disease, 13: 
15050120.  
 65 
 
15. Kara, B. (2009). Herbal product use in a sample of Turkish patients undergoing haemodialysis. Journal of Clinical 
Nursing, 18:2197-205. 
16. Loera, JA., Ortizb, CR. and Kuoa, YF. (2007). Predictors of complementary and alternative medicine use among older 
Mexican Americans. Complementary Therapies in Clinical Practice, 13: 224–31.  
17. Pillitteri, JL., Shiffman, S., Rohay, JM., Harkins, AM.,Burton, SL. and  Wadden, TA. (2008). Use of dietary 
supplements for weight loss in the United States: results of a National Survey. Obesity, 16: 790–796. 
18. Pittler, MH. and Ernst, E. (2005). Complementary therapies for reducing body weight: a systematic review. 
International Journal of Obesity, 29:1030–38. 
19. Saper, RB., Eisenberg, DM. and Phillips, RS. (2004). Common dietary supplements for weight loss. American Family 
Physician, 70:1731-8. 
20. Satman I ve TURDEP-II Çalışma Grubu http://www.turkendokrin.org/files/file/TURDEP_II_2011.pdf  (Access date: 
26.08.2016) 
21. Sharpe, PA., Blanck, HM., Williams, JE., Ainsworth, BE. and Conway, JM. (2007). Use of complementary and 
alternative medicine for weight control in the United States. Journal of Alternative and Complementary Medicine, 13: 
217–222. 
22. Steyer, TE. and Ables, A. (2009). Complementary and alternative therapies for weight loss. Primary Care., 36:395-406.  
23. WHO (2016). Obesity and overweight.  http://www.who.int/mediacentre/factsheets/fs311/en/ (Access date:26.08). 
